Om

Virax Biolabs Group Ltd. is a company specializing in the development and distribution of diagnostic testing kits and related products for the detection and management of viral diseases. The primary purpose of Virax Biolabs is to provide healthcare solutions that aid in the early detection of viral pathogens, a crucial step in preventing the spread of infectious diseases and enabling effective medical intervention. Its products are vital across various sectors including healthcare institutions, government health departments, and research organizations. The company's innovations are particularly significant amid global health crises, offering crucial tools for public health surveillance and response. By serving a diverse market, Virax Biolabs plays a key role in supporting public health initiatives and enhancing the capacity of healthcare systems to manage viral threats effectively. The company's operations underscore the importance of advancing medical diagnostics to safeguard community health and well-being.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I VIRAX BIOLABS GROUP MED ENDAVU: Køb Virax Biolabs Group ($VRAX) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Virax Biolabs Group, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.